SP1 and cancer: It has already been shown that Sp1 overexpression can induce the restoration of the telomere damage-dependent senescent phenotype to a young phenotype to some extent.92 Therefore, there is no doubt that the modulation of this barrier mechanism simply via changing Sp1 status may open a new avenue for the adjustment of nuclear trafficking in senescence, cancers and neurodegenerative disorders.